Healthcare perspectives from The Economist Intelligence Unit

Color

#DB444B

Hero Carousel

Spotlight

Bringing healthcare to hard-hit areas in Bangladesh

YouTube

https://www.youtube.com/channel/UCQDMOSbJtqrtNzif5rS22OQ

Slideshare

http://www.slideshare.net/economistintelligenceunit

Pinterest

https://www.pinterest.com/theeiu/

The Pharma Summit 2013: Pharma on trial

Ben Goldacre explains how Pharma can cure its pooly image through transparent and thorough trials of its products.

The Pharma Summit 2013: New collaboration models

The panel talks through the most promising new collaboration models for the Pharma industry, whilst looking at some of the challenges involved in implementing them.

Pharma’s value proposition

The Pharma Summit 2011 brings together top pharma players to present an outlook of the pharma industry in the long term. In this video David Redfern, Chief Strategy Officer at GlaxoSmithKline, discusses how the industry must change.

Innovation to benefit people

In this video, part of The Innovation Summit 2011, the panellists debate what is the future of medicine and what are the most important psychological, demographic, and economic trends that will affect innovators in health and well-being.

On innovative approaches to orphan diseases

In this panel of the The Pharma Summit 2011, Nicolas Sireau, Chairman at AKU Society, puts forward his ideas on how to reorient the pharma industry to be able to enter this neglected market and build a profitable business model based on innovation.

A new model for healthcare

This video shows a session of The Pharma Summit 2011 in which James Allen Heywood, Co-founder and Chairman at PatientsLikeMe, explains how he sees opportunities opening up for the pharma industry in new healthcare models.

Where’s hot and where’s not

This video shows a session of the The Pharma Summit 2011 exploring how markets are developing and creating new opportunities for the pharma industry and providing an informed viewpoint on the key issues facing the industry in this area.

On the future for research led-pharma

In this video, John Lechleite, President and Chief Executive Officer at Eli Lilly, opens The Pharma Summit 2011 by sharing his views on the future of the industry, and poses the question: can big pharma can continue to be research-led?

David Redfern: Pharma’s value proposition

David Redfern, CFO of GlaxoSmithKline, talks about how manifold challenges to the Pharma industry have led to a significant overhaul in the strategy of his organization.

Pharma Summit 2011 - Chair's closing remarks

In this video, Iain Scott, Managing Editor, Business Research at the Economist Intelligence Unit, provides his final remarks to close the The Pharma Summit 2011.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week